RMD vs SAABY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RMD · ResMed$235.30 ▼ 1.68%
SAABY · SAAB AB UNSPN ADS EACH REP 0.5 ORD SHS$30.50 ▼ 1.90%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RMD -4.9%
- SAABY +10.5%
Head to head
| Metric | RMD | SAABY |
|---|---|---|
| Price | $235.30 | $30.50 |
| Change today | ▼ 1.68% | ▼ 1.90% |
| Market cap | $33.10B | $33.07B |
| Return, 3 months | +7.2% | -11.1% |
| Return, year to date | -1.5% | +5.5% |
| Return, 1 year | -5.4% | +12.5% |
| P/E (TTM) | 21.4 | 41.2 |
| P/B | 5.6 | 0.4 |
| P/E percentile vs own 5y | 7th | – |
| Dividend yield | 1.05% | 0.41% |
| Revenue growth (YoY, latest qtr) | +8.6% | – |
| Net profit growth (YoY) | +1.0% | – |
| Gross margin | 61.1% | – |
| Operating margin | 33.8% | – |
| Net margin | 26.9% | – |
| Return on equity | 24.3% | – |
| Analyst target vs. price | +14.2% | – |
| Analyst buy share | 44% | – |
| RSI (14) | 48 | 39 |
| 30-day volatility | 39.2% | 32.1% |
| Max drawdown, 1 year | -33.4% | -38.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- RMD is the largest of the group by market value.
- SAABY has returned the most over the past year.
- RMD carries the lowest trailing P/E.
- RMD pays the highest dividend yield.
- SAABY has been the calmest stock over the last 30 days.